Interactions of the orexin/hypocretin neurones and the histaminergic system

Acta Physiologica

Volumn 213, Issue 2, 2015, Pages 321-333

  Sundvik, M ^a   Panula, P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoimmune; Histamine; Hypocretin orexin; Mouse; Narcolepsy; Zebrafish

Indexed keywords

HISTAMINE; NEUROTRANSMITTER; OREXIN; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

BRAIN NERVE CELL; CATAPLEXY; CHOLINERGIC SYSTEM; DOPAMINERGIC SYSTEM; HISTAMINE RELEASE; HISTAMINERGIC SYSTEM; HUMAN; HYPERSOMNIA; INNERVATION; NARCOLEPSY; NERVE CELL; NERVOUS SYSTEM; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEROTONINERGIC SYSTEM; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; VERTEBRATE; WAKEFULNESS; ZEBRA FISH; ANIMAL; BRAIN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; HISTAMINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NARCOLEPSY; NEURONS; NEUROPEPTIDES; WAKEFULNESS;

EID: 84936845558     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12432     Document Type: Review

References (132)

1. Ahrens, M.B., Li, J.M., Orger, M.B., Robson, D.N., Schier, A.F., Engert, F. & Portugues, R. 2012. Brain-wide neuronal dynamics during motor adaptation in zebrafish. Nature 485, 471-477.
2. Airaksinen, M.S., Paetau, A., Paljarvi, L., Reinikainen, K., Riekkinen, P., Suomalainen, R. & Panula, P. 1991. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 44, 465-481.
3. Alam, M.N., Gong, H., Alam, T., Jaganath, R., McGinty, D. & Szymusiak, R. 2002. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol 538, 619-631.
4. Anaclet, C., Parmentier, R., Ouk, K., Guidon, G., Buda, C., Sastre, J.P., Akaoka, H., Sergeeva, O.A., Yanagisawa, M., Ohtsu, H., Franco, P., Haas, H.L. & Lin, J.S. 2009. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 29, 14423-14438.
5. Anichtchik, O.V., Peitsaro, N., Rinne, J.O., Kalimo, H. & Panula, P. 2001. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8, 707-716.
6. Arrang, J.M., Garbarg, M. & Schwartz, J.C. 1983. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302, 832-837.
7. Barnes, W.G. & Hough, L.B. 2002. Membrane-bound histamine N-methyltransferase in mouse brain: possible role in the synaptic inactivation of neuronal histamine. J Neurochem 82, 1262-1271.
8. Bassetti, C.L., Baumann, C.R., Dauvilliers, Y., Croyal, M., Robert, P. & Schwartz, J.C. 2010. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res 19, 620-623.
9. Beck, P., Odle, A., Wallace-Huitt, T., Skinner, R.D. & Garcia-Rill, E. 2008. Modafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonists. Sleep 31, 1647-1654.
10. Beuckmann, C.T., Sinton, C.M., Williams, S.C., Richardson, J.A., Hammer, R.E., Sakurai, T. & Yanagisawa, M. 2004. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 24, 4469-4477.
11. Browman, K.E., Komater, V.A., Curzon, P., Rueter, L.E., Hancock, A.A., Decker, M.W. & Fox, G.B. 2004. Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153, 69-76.
12. Burgess, H.A. & Granato, M. 2007a. Modulation of locomotor activity in larval zebrafish during light adaptation. J Exp Biol 210, 2526-2539.
13. Burgess, H.A. & Granato, M. 2007b. Sensorimotor gating in larval zebrafish. J Neurosci 27, 4984-4994.
14. Burgess, C.R., Oishi, Y., Mochizuki, T., Peever, J.H. & Scammell, T.E. 2013. Amygdala lesions reduce cataplexy in orexin knock-out mice. J Neurosci 33, 9734-9742.
15. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch, T.E., Nakazato, M., Hammer, R.E., Saper, C.B. & Yanagisawa, M. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451.
16. Chikahisa, S., Kodama, T., Soya, A., Sagawa, Y., Ishimaru, Y., Sei, H. & Nishino, S. 2013. Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states. PLoS ONE 8, e78434.
17. Clark, K.J., Voytas, D.F. & Ekker, S.C. 2011. A TALE of two nucleases: gene targeting for the masses? Zebrafish 8, 147-149.
18. Dai, H., Kaneko, K., Kato, H., Fujii, S., Jing, Y., Xu, A., Sakurai, E., Kato, M., Okamura, N., Kuramasu, A. & Yanai, K. 2007. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci Res 57, 306-313.
19. Dauvilliers, Y., Delallee, N., Jaussent, I., Scholz, S., Bayard, S., Croyal, M., Schwartz, J.C. & Robert, P. 2012. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 35, 1359-1366.
20. Dauvilliers, Y., Bassetti, C., Lammers, G.J., Arnulf, I., Mayer, G., Rodenbeck, A., Lehert, P., Ding, C.L., Lecomte, J.M. & Schwartz, J.C. 2013. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol 12, 1068-1075.
21. Douglass, A.D., Kraves, S., Deisseroth, K., Schier, A.F. & Engert, F. 2008. Escape behavior elicited by single, channelrhodopsin-2-evoked spikes in zebrafish somatosensory neurons. Curr Biol 18, 1133-1137.
22. Doyon, Y., McCammon, J.M., Miller, J.C., Faraji, F., Ngo, C., Katibah, G.E., Amora, R., Hocking, T.D., Zhang, L., Rebar, E.J., Gregory, P.D., Urnov, F.D. & Amacher, S.L. 2008. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 26, 702-708.
23. Drutel, G., Peitsaro, N., Karlstedt, K., Wieland, K., Smit, M.J., Timmerman, H., Panula, P. & Leurs, R. 2001. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59, 1-8.
24. Elbaz, I., Yelin-Bekerman, L., Nicenboim, J., Vatine, G. & Appelbaum, L. 2012. Genetic ablation of hypocretin neurons alters behavioral state transitions in zebrafish. J Neurosci 32, 12961-12972.
25. Ericson, H., Watanabe, T. & Kohler, C. 1987. Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol 263, 1-24.
26. Eriksson, K.S., Peitsaro, N., Karlstedt, K., Kaslin, J. & Panula, P. 1998. Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems. Eur J Neuorsci 10, 3799-3812.
27. Eriksson, K.S., Sergeeva, O., Brown, R.E. & Haas, H.L. 2001. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21, 9273-9279.
28. Ferraro, L., Tanganelli, S., O'Connor, W.T., Antonelli, T., Rambert, F. & Fuxe, K. 1996. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 306, 33-39.
29. Foley, J.E., Maeder, M.L., Pearlberg, J., Joung, J.K., Peterson, R.T. & Yeh, J.R. 2009. Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. Nat Protoc 4, 1855-1867.
30. Fukushima, Y., Shindo, T., Anai, M., Saitoh, T., Wang, Y., Fujishiro, M., Ohashi, Y., Ogihara, T., Inukai, K., Ono, H. et al. 2003. Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice. Eur J Pharmacol 468, 47-58.
31. Garbarg, M., Barbin, G., Bischoff, S., Pollard, H. & Schwartz, J.C. 1974. Evidence for a specific decarboxylase involved in histamine synthesis in an ascending pathway in rat brain. Agents Actions 4, 181.
32. Gerashchenko, D. & Shiromani, P.J. 2004. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Res 1019, 162-169.
33. Gondard, E., Anaclet, C., Akaoka, H., Guo, R.X., Zhang, M., Buda, C., Franco, P., Kotani, H. & Lin, J.S. 2013. Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology 38, 1015-1031.
34. Granato, M., van Eeden, F.J., Schach, U., Trowe, T., Brand, M., Furutani-Seiki, M., Haffter, P., Hammerschmidt, M., Heisenberg, C.P., Jiang, Y.J., Kane, D.A., Kelsh, R.N., Mullins, M.C., Odenthal, J. & Nusslein-Volhard, C. 1996. Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development, 123, 399-413.
35. Guo, R.X., Anaclet, C., Roberts, J.C., Parmentier, R., Zhang, M., Guidon, G., Buda, C., Sastre, J.P., Feng, J.Q., Franco, P., Brown, S.H., Upton, N., Medhurst, A.D. & Lin, J.S. 2009. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol 157, 104-117.
36. Haas, H. & Panula, P. 2003. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4, 121-130.
37. Haffter, P., Granato, M., Brand, M., Mullins, M.C., Hammerschmidt, M., Kane, D.A., Odenthal, J., van Eeden, F.J., Jiang, Y.J., Heisenberg, C.P. et al. 1996. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development, 123, 1-36.
38. Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton, C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M. & Sakurai, T. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345-354.
39. Hill, S.J., Ganellin, C.R., Timmerman, H., Schwartz, J.C., Shankley, N.P., Young, J.M., Schunack, W., Levi, R. & Haas, H.L. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49, 253-278.
40. Hondo, M., Nagai, K., Ohno, K., Kisanuki, Y., Willie, J.T., Watanabe, T., Yanagisawa, M. & Sakurai, T. 2010. Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states. Acta Physiol (Oxf) 198, 287-294.
41. Inoue, I., Yanai, K., Kitamura, D., Taniuchi, I., Kobayashi, T., Niimura, K. & Watanabe, T. 1996. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 93, 13316-13320.
42. Ishizuka, T., Murotani, T. & Yamatodani, A. 2010. Modanifil activates the histaminergic system through the orexinergic neurons. Neurosci Lett 483, 193-196.
43. John, J., Thannickal, T.C., McGregor, R., Ramanathan, L., Ohtsu, H., Nishino, S., Sakai, N., Yamanaka, A., Stone, C., Cornford, M. & Siegel, J.M. 2013. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann Neurol 74, 786-793.
44. Kalogiannis, M., Hsu, E., Willie, J.T., Chemelli, R.M., Kisanuki, Y.Y., Yanagisawa, M. & Leonard, C.S. 2011. Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice. PLoS ONE 6, e18697.
45. Kanbayashi, T., Kodama, T., Kondo, H., Satoh, S., Inoue, Y., Chiba, S., Shimizu, T. & Nishino, S. 2009. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 32, 181-187.
46. Karlstedt, K., Senkas, A., Ahman, M. & Panula, P. 2001. Regional expression of the histamine H(2) receptor in adult and developing rat brain. Neuroscience 102, 201-208.
47. Kaslin, J. & Panula, P. 2001. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J Comp Neurol 440, 342-377.
48. Kaslin, J., Nystedt, J.M., Ostergard, M., Peitsaro, N. & Panula, P. 2004. The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 24, 2678-2689.
49. Katzav, A., Arango, M.T., Kivity, S., Tanaka, S., Givaty, G., Agmon-Levin, N., Honda, M., Anaya, J.M., Chapman, J. & Shoenfeld, Y. 2013. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J Autoimmun 45, 24-30.
50. Kinnunen, A., Lintunen, M., Karlstedt, K., Fukui, H. & Panula, P. 1998. In situ detection of H1-receptor mRNA and absence of apoptosis in the transient histamine system of the embryonic rat brain. J Comp Neurol 394, 127-137.
51. Kukko-Lukjanov, T.K. & Panula, P. 2003. Subcellular distribution of histamine, GABA and galanin in tuberomamillary neurons in vitro. J Chem Neuroanat 25, 279-292.
52. Kukko-Lukjanov, T.K., Soini, S., Taira, T., Michelsen, K.A., Panula, P. & Holopainen, I.E. 2006. Histaminergic neurons protect the developing hippocampus from kainic acid-induced neuronal damage in an organotypic coculture system. J Neurosci 26, 1088-1097.
53. de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S. 2nd, Frankel, W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M. & Sutcliffe, J.G. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95, 322-327.
54. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. & Mignot, E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365-376.
55. Lin, L., Wisor, J., Shiba, T., Taheri, S., Yanai, K., Wurts, S., Lin, X., Vitaterna, M., Takahashi, J., Lovenberg, T.W., Koehl, M., Uhl, G., Nishino, S. & Mignot, E. 2002. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 23, 2203-2211.
56. Lin, J.S., Dauvilliers, Y., Arnulf, I., Bastuji, H., Anaclet, C., Parmentier, R., Kocher, L., Yanagisawa, M., Lehert, P., Ligneau, X., Perrin, D., Robert, P., Roux, M., Lecomte, J.M. & Schwartz, J.C. 2008. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 30, 74-83.
57. Lin, J.S., Sergeeva, O.A. & Haas, H.L. 2011. Histamine H3 receptors and sleep-wake regulation. J Pharmacol Exp Ther 336, 17-23.
58. Liu, C., Wilson, S.J., Kuei, C. & Lovenberg, T.W. 2001. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299, 121-130.
59. Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, C.B., Yanagisawa, M. & Elmquist, J.K. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435, 6-25.
60. Matsuzaki, K., Katakura, M., Hara, T., Li, G., Hashimoto, M. & Shido, O. 2009. Proliferation of neuronal progenitor cells and neuronal differentiation in the hypothalamus are enhanced in heat-acclimated rats. Pflugers Arch 458, 661-673.
61. Meng, X., Noyes, M.B., Zhu, L.J., Lawson, N.D. & Wolfe, S.A. 2008. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol 26, 695-701.
62. Merickel, A. & Edwards, R.H. 1995. Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology 34, 1543-1547.
63. Mieda, M., Willie, J.T., Hara, J., Sinton, C.M., Sakurai, T. & Yanagisawa, M. 2004. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 101, 4649-4654.
64. Mieda, M., Hasegawa, E., Kisanuki, Y.Y., Sinton, C.M., Yanagisawa, M. & Sakurai, T. 2011. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 31, 6518-6526.
65. Migaud, M., Batailler, M., Segura, S., Duittoz, A., Franceschini, I. & Pillon, D. 2010. Emerging new sites for adult neurogenesis in the mammalian brain: a comparative study between the hypothalamus and the classical neurogenic zones. Eur J Neurosci 32, 2042-2052.
66. Mignot, E., Lin, L., Rogers, W., Honda, Y., Qiu, X., Lin, X., Okun, M., Hohjoh, H., Miki, T., Hsu, S., Leffell, M., Grumet, F., Fernandez-Vina, M., Honda, M. & Risch, N. 2001. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68, 686-699.
67. Mignot, E., Taheri, S. & Nishino, S. 2002. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 5(Suppl), 1071-1075.
68. Monti, J.M., Pellejero, T. & Jantos, H. 1986. Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat. J Neural Transm 66, 1-11.
69. Monti, J.M., Jantos, H., Boussard, M., Altier, H., Orellana, C. & Olivera, S. 1991. Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness. Eur J Pharmacol 205, 283-287.
70. Mussolino, C., Morbitzer, R., Lutge, F., Dannemann, N., Lahaye, T. & Cathomen, T. 2011. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39, 9283-9293.
71. Naumann, E.A., Kampff, A.R., Prober, D.A., Schier, A.F. & Engert, F. 2010. Monitoring neural activity with bioluminescence during natural behavior. Nat Neurosci 13, 513-520.
72. Nishino, S., Fujiki, N., Ripley, B., Sakurai, E., Kato, M., Watanabe, T., Mignot, E. & Yanai, K. 2001. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 313, 125-128.
73. Nishino, S., Sakurai, E., Nevsimalova, S., Yoshida, Y., Watanabe, T., Yanai, K. & Mignot, E. 2009. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 32, 175-180.
74. Ohtsu, H., Tanaka, S., Terui, T., Hori, Y., Makabe-Kobayashi, Y., Pejler, G., Tchougounova, E., Hellman, L., Gertsenstein, M., Hirasawa, N. et al. 2001. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 502, 53-56.
75. Orger, M.B., Kampff, A.R., Severi, K.E., Bollmann, J.H. & Engert, F. 2008. Control of visually guided behavior by distinct populations of spinal projection neurons. Nat Neurosci 11, 327-333.
76. Panula, P. & Nuutinen, S. 2013. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 14, 472-487.
77. Panula, P., Yang, H.Y. & Costa, E. 1984. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81, 2572-2576.
78. Panula, P., Chen, Y.C., Priyadarshini, M., Kudo, S., Semenova, S., Sundvik, M. & Sallinen, V. 2010. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 40, 46-57.
79. Parmentier, R., Ohtsu, H., Djebbara-Hannas, Z., Valatx, J.L., Watanabe, T. & Lin, J.S. 2002. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22, 7695-7711.
80. Parmentier, R., Anaclet, C., Guhennec, C., Brousseau, E., Bricout, D., Giboulot, T., Bozyczko-Coyne, D., Spiegel, K., Ohtsu, H., Williams, M. & Lin, J.S. 2007. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 73, 1157-1171.
81. Passani, M.B., Lin, J.S., Hancock, A., Crochet, S. & Blandina, P. 2004. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 25, 618-625.
82. Peitsaro, N., Sundvik, M., Anichtchik, O.V., Kaslin, J. & Panula, P. 2007. Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior. Biochem Pharmacol 73, 1205-1214.
83. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G. & Kilduff, T.S. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996-10015.
84. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R. et al. 2000. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6, 991-997.
85. Porkka-Heiskanen, T., Zitting, K.M. & Wigren, H.K. 2013. Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiol (Oxf), 208, 311-328.
86. Prober, D.A., Rihel, J., Onah, A.A., Sung, R.J. & Schier, A.F. 2006. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 26, 13400-13410.
87. Rihel, J., Prober, D.A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S.J., Kokel, D., Rubin, L.L., Peterson, R.T. & Schier, A.F. 2010. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351.
88. Rizk, A., Curley, J., Robertson, J. & Raber, J. 2004. Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neuorsci 19, 1992-1996.
89. Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S.A. & Ekker, S.C. 2007. P53 Activation by Knockdown Technologies. PLoS Genet 3, e78.
90. Sakurai, T. 2007. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8, 171-181.
91. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S. et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585.
92. Sallinen, V., Sundvik, M., Reenila, I., Peitsaro, N., Khrustalyov, D., Anichtchik, O., Toleikyte, G., Kaslin, J. & Panula, P. 2009a. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 109, 403-415.
93. Sallinen, V., Torkko, V., Sundvik, M., Reenila, I., Khrustalyov, D., Kaslin, J. & Panula, P. 2009b. MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 108, 719-731.
94. Sander, J.D. & Joung, J.K. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32, 347-355.
95. Saper, C.B. 2013. Restoration: potential for compensatory changes in numbers of neurons in adult human brain. Ann Neurol 74, 762-764.
96. Saper, C.B., Chou, T.C. & Scammell, T.E. 2001. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24, 726-731.
97. Saper, C.B., Fuller, P.M., Pedersen, N.P., Lu, J. & Scammell, T.E. 2010. Sleep state switching. Neuron 68, 1023-1042.
98. Scammell, T.E., Estabrooke, I.V., McCarthy, M.T., Chemelli, R.M., Yanagisawa, M., Miller, M.S. & Saper, C.B. 2000. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20, 8620-8628.
99. Schlicker, E., Werthwein, S. & Zentner, J. 1999. Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain. Fundam Clin Pharmacol 13, 120-122.
100. Schone, C., Cao, Z.F., Apergis-Schoute, J., Adamantidis, A., Sakurai, T. & Burdakov, D. 2012. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J Neurosci 32, 12437-12443.
101. Schone, C., Apergis-Schoute, J., Sakurai, T., Adamantidis, A. & Burdakov, D. 2014. Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep 7, 697-704.
102. Sherin, J.E., Elmquist, J.K., Torrealba, F. & Saper, C.B. 1998. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 18, 4705-4721.
103. Spitzer, N.C. 2012. Activity-dependent neurotransmitter respecification. Nat Rev Neurosci 13, 94-106.
104. Sundvik, M. & Panula, P. 2012. The organization of the histaminergic system in adult zebrafish (Danio rerio) brain: neuron number, location and co-transmitters. J Comp Neurol 520, 3827-3845.
105. Sundvik, M., Kudo, H., Toivonen, P., Rozov, S., Chen, Y.C. & Panula, P. 2011. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J 25, 4338-4347.
106. Sundvik, M., Chen, Y.C. & Panula, P. 2013. Presenilin1 regulates histamine neuron development and behavior in zebrafish, Danio rerio. J Neurosci 33, 1589-1597.
107. Takahashi, K., Suwa, H., Ishikawa, T. & Kotani, H. 2002. Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110, 1791-1799.
108. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M. & Siegel, J.M. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469-474.
109. Torrealba, F., Yanagisawa, M. & Saper, C.B. 2003. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119, 1033-1044.
110. Tritsch, N.X., Ding, J.B. & Sabatini, B.L. 2012. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 490, 262-266.
111. Trivedi, P., Yu, H., MacNeil, D.J., Van der Ploeg, L.H. & Guan, X.M. 1998. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438, 71-75.
112. Trottier, S., Chotard, C., Traiffort, E., Unmehopa, U., Fisser, B., Swaab, D.F. & Schwartz, J.C. 2002. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Res 939, 52-64.
113. Valko, P.O., Gavrilov, Y.V., Yamamoto, M., Reddy, H., Haybaeck, J., Mignot, E., Baumann, C.R. & Scammell, T.E. 2013. Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann Neurol 74, 794-804.
114. Vanni-Mercier, G., Gigout, S., Debilly, G. & Lin, J.S. 2003. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res 144, 227-241.
115. Waldmeier, P.C. 1987. Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). J Neural Transm Suppl 23, 55-72.
116. Watanabe, T., Taguchi, Y., Shiosaka, S., Tanaka, J., Kubota, H., Terano, Y., Tohyama, M. & Wada, H. 1984. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295, 13-25.
117. Whitfield, T.T., Granato, M., van Eeden, F.J., Schach, U., Brand, M., Furutani-Seiki, M., Haffter, P., Hammerschmidt, M., Heisenberg, C.P., Jiang, Y.J., Kane, D.A., Kelsh, R.N., Mullins, M.C., Odenthal, J. & Nusslein-Volhard, C. 1996. Mutations affecting development of the zebrafish inner ear and lateral line. Development 123, 241-254.
118. Williams, R.H., Chee, M.J., Kroeger, D., Ferrari, L.L., Maratos-Flier, E., Scammell, T.E. & Arrigoni, E. 2014. Optogenetic-mediated release of histamine reveals distal and autoregulatory mechanisms for controlling arousal. J Neurosci 34, 6023-6029.
119. Willie, J.T., Chemelli, R.M., Sinton, C.M., Tokita, S., Williams, S.C., Kisanuki, Y.Y., Marcus, J.N., Lee, C., Elmquist, J.K., Kohlmeier, K.A., Leonard, C.S., Richardson, J.A., Hammer, R.E. & Yanagisawa, M. 2003. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38, 715-730.
120. Willie, J.T., Renthal, W., Chemelli, R.M., Miller, M.S., Scammell, T.E., Yanagisawa, M. & Sinton, C.M. 2005. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience 130, 983-995.
121. Willie, J.T., Takahira, H., Shibahara, M., Hara, J., Nomiyama, M., Yanagisawa, M. & Sakurai, T. 2011. Ectopic overexpression of orexin alters sleep/wakefulness states and muscle tone regulation during REM sleep in mice. J Mol Neurosci 43, 155-161.
122. Wong, K.K., Ng, S.Y., Lee, L.T., Ng, H.K. & Chow, B.K. 2011. Orexins and their receptors from fish to mammals: a comparative approach. Gen Comp Endocrinol 171, 124-130.
123. Xu, Y., Tamamaki, N., Noda, T., Kimura, K., Itokazu, Y., Matsumoto, N., Dezawa, M. & Ide, C. 2005. Neurogenesis in the ependymal layer of the adult rat 3rd ventricle. Exp Neurol 192, 251-264.
124. Xu, Y.L., Gall, C.M., Jackson, V.R., Civelli, O. & Reinscheid, R.K. 2007. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500, 84-102.
125. Yamamoto, Y., Ueta, Y., Date, Y., Nakazato, M., Hara, Y., Serino, R., Nomura, M., Shibuya, I., Matsukura, S. & Yamashita, H. 1999. Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 65, 14-22.
126. Yamanaka, A., Tsujino, N., Funahashi, H., Honda, K., Guan, J.L., Wang, Q.P., Tominaga, M., Goto, K., Shioda, S. & Sakurai, T. 2002. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 290, 1237-1245.
127. Yokogawa, T., Marin, W., Faraco, J., Pezeron, G., Appelbaum, L., Zhang, J., Rosa, F., Mourrain, P. & Mignot, E. 2007. Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol 5, e277.
128. Yoshikawa, T., Naganuma, F., Iida, T., Nakamura, T., Harada, R., Mohsen, A.S., Kasajima, A., Sasano, H. & Yanai, K. 2013. Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61, 905-916.
129. Zecharia, A.Y., Yu, X., Gotz, T., Ye, Z., Carr, D.R., Wulff, P., Bettler, B., Vyssotski, A.L., Brickley, S.G., Franks, N.P. & Wisden, W. 2012. GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J Neurosci 32, 13062-13075.
130. Zhdanova, I.V. 2006. Sleep in zebrafish. Zebrafish 3, 215-226.
131. Zhdanova, I.V. 2011. Sleep and its regulation in zebrafish. Rev Neurosci 22, 27-36.
132. Zhdanova, I.V., Yu, L., Lopez-Patino, M., Shang, E., Kishi, S. & Guelin, E. 2008. Aging of the circadian system in zebrafish and the effects of melatonin on sleep and cognitive performance. Brain Res Bull 75, 433-441.